Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine

J Infect Dis. 1997 Feb:175 Suppl 1:S264-7. doi: 10.1093/infdis/175.supplement_1.s264.

Abstract

Monoclone-based IgM capture ELISAs were developed for each of the three poliovirus serotypes and compared with a neutralization assay for detecting response to trivalent oral poliovirus vaccine among 224 infants. The IgM-based response rates were significantly higher than the neutralizing antibody-based rates: 95% versus 83% to poliovirus type 1, 99% versus 94% to poliovirus type 2, and 89% versus 59% to poliovirus type 3. IgM responses to the first vaccine dose were significantly associated between serotypes, suggesting that some of the discordance may reflect a heterotypic IgM response. When the response rates in 4 vaccine formulation groups were compared, group differences using the two assays were similar for poliovirus types 1 and 2 but not for type 3. Therefore, IgM results using these assays may not be adequate substitutes for neutralizing antibody results when determining vaccine response.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Enzyme-Linked Immunosorbent Assay*
  • Humans
  • Immunoglobulin M
  • Infant
  • Mice
  • Mice, Inbred BALB C
  • Neutralization Tests*
  • Poliomyelitis / immunology*
  • Poliovirus / drug effects
  • Poliovirus / immunology*
  • Poliovirus Vaccine, Oral / immunology*
  • Poliovirus Vaccine, Oral / pharmacology

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin M
  • Poliovirus Vaccine, Oral